Israeli pharmaceutical giant Teva has been given the go-ahead to market its over-the-counter “morning after” pill, Plan B One Step. The American Food and Drug Administration (FDA) has approved the pill, which will be sold without a prescription to girls under 17.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Clean Energy Firm Completes Solar Project In North, South Israel
October 15, 2024
Cannabis Therapy Firm: CBD Jab Reduces Pain In Arthritic Dogs
October 15, 2024
US Government Funding Development Of Israeli Ebola Treatment
October 14, 2024
Security Firm Wins Prison Service Contract For Electronic Monitoring
October 14, 2024
Facebook comments